×

Diversifying your pharma portfolio

1:07 PM ET Mon, 7 April 2014

Mallinckrodt is buying drug maker Questcor for $5.6 billion. Barbara Ryan, FTI Consulting managing director, discusses consolidation in pharmaceuticals and shares what stocks she likes in the space.